Margherita Cavallin
Udine, 33100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BCL-2 Expression in AML Patients over 65 Years: Impact on Outcomes across Different Therapeutic Strategies.
Journal: Journal of clinical medicine
Published: August 27, 2021
Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: February 18, 2021
Cytomegalovirus Prophylaxis versus Pre-emptive Strategy: Different CD4+ and CD8+ T Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: October 30, 2020
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Journal: European journal of haematology
Published: June 07, 2017
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.
Journal: Leukemia research
Published: December 30, 2016
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
Journal: American journal of hematology
Published: May 28, 2015
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Journal: American journal of hematology
Published: March 04, 2013
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Journal: Annals of hematology
Published: March 05, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026